跳至主要内容
临床试验/ISRCTN10169595
ISRCTN10169595已完成未知

Does intra­operative use of the MarginProbe device reduce the need for further re­-excision procedures after conservation surgery for breast cancer?

niversity Hospital of South Manchester0 个研究点目标入组 467 人开始时间: 2017年3月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
467

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Women aged 18-90 years with DCIS or Invasive Breast cancer containing DCIS diagnosed histopathologically
  • 2. Histologically diagnosed DCIS or invasive lobular cancer in core biopsy (B5a or B5b). Invasive lobular carcinoma does not require concomitant DCIS.
  • 3. Tumour size 1.5cm - 4cm and undergoing BCS
  • 4. Written informed consent

排除标准

  • 1. Unsuitable for BCS on basis of tumour size (>4cm) or stage.
  • 2. Radiotherapy contraindicated.
  • 3. No histopathological evidence of DCIS or invasive lobular cancer.
  • 4. Small invasive cancers (<1.5cm)
  • 5. Multicentric Disease (histologically diagnosed cancer in two different quadrants of the breast), unless resected in a single specimen
  • 6. Bilateral disease (diagnosed cancer in both breasts)
  • 7. Neoadjuvant systemic therapy
  • 8. Previous radiation in the operated breast
  • 9. Implants in the operated breast
  • 10. Pregnancy
  • 11. Lactation
  • 12. Cryo-assisted localisation
  • 13. Patients who are undergoing full cavity excision following removal of the main lumpectomy specimen during initial lumpectomy procedure.

研究者

发起方
niversity Hospital of South Manchester

相似试验

Does intra­operative Marginprobe use reduce... | 临床试验